CRB Monitor Securities Database Updates
During the week of July 10 - 16, 2023, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of July 10 - 16, 2023:
| Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
| Tier 1A |
147 |
123 / 22 / 2 |
+0 | -1 | -1 |
| Tier 1B |
728 |
577 / 149 / 2 |
+1 | -0 | +1 |
| Tier 2 |
339 |
315 / 20 / 4 |
+1 | -0 | +1 |
| Tier 3 |
504 |
476 / 27 / 1 |
+0 | -0 | +0 |
| Total Issuances |
1,718 |
1,491 / 218 / 9 |
+2 | -1 | +1 |
| Total Issuers (w/o Pre-IPOs) |
1,293 |
- |
+1 | -0 | +1 |
| Total Issuers (w/ Pre-IPOs) |
1,302 |
- |
+1 | -0 | +1 |
- Removed 1 Tier 1A Security:
- -1 = CRB Tier Downgraded to Tier 2: ("Steep Hill Inc.")
- Rationale = Steep Hill Inc., formerly Canbud Distribution Corporation, previously focused on providing products and services, including analytical testing services within the hemp and cannabis market sectors in Canada and USA. Steep Hill Inc. closed its analytical testing facility in Canada in order to focus on its US business. However, Steep Hill Inc. subsequently agreed to mutual termination of all licensing agreements in the USA and terminated all staff and consulting agreements in the USA. As a result, the company has no operations in Canada and USA and is currently evaluating its strategic alternatives. The company has shutdown its operation and and is in the process of restructuring its business. Given Steep Hill Inc.'s previous involvement in cannabis, it is possible that the company decides to re-enter the industry. CRB Monitor will continue to include Steep Hill Inc. until the company explicitly exits the cannabis industry and/or the company ceases to be a reporting issuer. In the meantime, CRB Monitor will classify Steep Hill Inc. as a "SPAC" (special purpose acquisition company), a company with no commercial operations searching for an acquisition in the cannabis industry. CRB Monitor includes all cannabis-related SPACs which are assigned to Tier 2.
- -1 = CRB Tier Downgraded to Tier 2: ("Steep Hill Inc.")
- Added 1 Tier 1B Security:
- +1 = New CRB: ("Zyus Life Sciences Inc.")
- Added 1 Tier 2 Security:
- +1 = CRB Tier Downgraded to Tier 2: ("Steep Hill Inc.")
- +1 = CRB Tier Downgraded to Tier 2: ("Steep Hill Inc.")
All newly-identified CRBs during the week:
| Company Name |
Tier |
Pure-Play | Sector | Description |
| 1B | Yes | Owner/ Investor | ZYUS Life Sciences Corporation is a Canadian-based life sciences company focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and innovative exempt market therapeutics. Through clinical research, ZYUS is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product candidates and intellectual property activities to protect its novel formulations. Additionally, ZYUS is dedicated to delivering high quality, cGMP / EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The ZYUS vision is to reimagine the potential of pain therapeutics by elevating cannabinoid formulations as a standard of care in pursuit of transformational impact on patients' lives. ZYUS Life Sciences Corporation, through its wholly-owned subsidiary Zyus Life Sciences Inc., indirectly holds cannabis licenses issued under Health Canada. |